Risk Factors for Life-Threatening Asthma Attacks and Asthma-Related Mortality in Children-A Systematic Review

Aleksandra Gawlik-Lipinski1, Sarah Hassen1, Manisha Ramphul1,2

  • 1University of Leicester, Leicester, UK.

Pediatric Pulmonology
|August 19, 2025
PubMed

Insights

Identifying risk factors for severe asthma attacks in children and young people (CYP) is crucial. High salbutamol use, previous hospitalizations, and socioeconomic status were linked to intensive care unit admissions in CYP with asthma.

Area of Science:

  • Pediatric Pulmonology
  • Epidemiology
  • Asthma Research

Background:

  • Asthma mortality and life-threatening attacks pose significant risks in children and young people (CYP).
  • Limited evidence exists regarding specific risk factors for severe asthma exacerbations in CYP.
  • This systematic review aims to consolidate current knowledge on these risk factors.

Purpose of the Study:

  • To systematically review and synthesize observational studies identifying risk factors for life-threatening asthma attacks and asthma mortality in children and young people (CYP).
  • To inform risk prediction strategies in pediatric asthma care.

Main Methods:

  • Systematic review adhering to PRISMA guidelines, registered on PROSPERO.
  • Included observational studies (0-18 years) published in English from 2000 onwards, focusing on asthma mortality and intensive care unit (ICU) admissions.
  • Searched CINAHL, MEDLINE, Cochrane Library, and Scopus; synthesized results narratively.

Main Results:

  • Six studies (five retrospective cohort, one case-control) from high-income countries were included.
  • Factors associated with ICU admissions included high salbutamol use, prior hospitalization, low socioeconomic status, allergies, Black ethnicity, asthma medication prescription, pneumonia history, rural location, adolescence, paternal asthma, and comorbidities.
  • Black ethnicity was associated with a sevenfold increased risk of asthma mortality compared to White children.

Conclusions:

  • A small number of heterogeneous studies highlight the need for more robust epidemiological research.
  • Improved risk prediction models are essential for managing near-fatal and fatal asthma attacks in CYP.
  • Current evidence suggests significant disparities and risk factors impacting severe asthma outcomes in pediatric populations.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
581
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
463